Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone in Androgen Independent Prostate Cancer
NCT00140478Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Feb 2005
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone in prostate cancer (PCa), sponsored by Dana-Farber Cancer Institute. Started Feb 2005; status: completed.
02
Drugs
mifepristone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00140478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140478.